NATIXIS // 2021 Universal Registration Document
3 RISK FACTORS, RISK MANAGEMENT AND PILLAR III Basel 3 Pillar III disclosures
Cross-reference table 3.3.7
Cross-reference table between Articles of the CRR, Basel Committee/EBA tables and statements, and the Pillar III report
Universal registration document page
CRR Article
Basel Committee/EBA tables and statements
184
Article 438 (d)
EU OV1 – Overview of total risk-weighted asset exposures
Article 447 (a) to (g) Article 438 (b)
EU KM1 – Model for key indicators
186 177
Article 438 (f) Article 436 (c) Article 436 (b)
EU INS1 – Insurance holdings
EU LI1 – Differences between accounting and regulatory scopes of consolidation and the mapping of the financial statements with regulatory risk categories
165-166
EU LI3 – Summary of the differences between consolidation scopes (entity by entity)
167 165 165 177
Article 436 (b) and (d)
EU LIA – Explanation of differences between accounting and regulatory exposure amounts
Article 436 (f), (g) and (h)
EU LIB – Other qualitative information on the scope
Article 436 (e)
EU PV1 – Value adjustments for conservative valuation purposes (PVA)
EU CC1 – Composition of regulatory capital
169 to 172
Article 437 (a), (d), (e) and (f)
Article 437 (a) Article 440 (a) Article 440 (b)
EU CC2 – Reconciliation between regulatory capital and the balance sheet in the audited financial statements EU CCyB1 – Geographical distribution of relevant credit exposures used in the countercyclical capital buffer
173-174
176 176 180 181 183 180 229 228 230 190 188 190 189 189 191 191 192 192 193 194 203 187 218 194 203 213 219 213 214 216 217 217 219 220 221 222 223 223 222 187
EU CCyB2- Amount of the institution-specific countercyclical capital buffer
EU LR1 – LRSum – Summary of the reconciliation between accounting assets and exposures for leverage ratio purposes
Article 451 (1) (b)
Article 451 (a) and (b) Article 451(3)
EU LR2 – LRCom – Leverage ratio – common disclosure
Article 451 (1) (b)
EU LR3- LRSpl – Breakdown of on-balance sheet exposures (excluding derivatives, SFTs and exempt exposures)
EU LRA – Publication of qualitative information on the leverage ratio
Article 451 (1) (d) and (e)
Article 435 (a)(4) Article 451 (1) Article 451 (a)(2) Article 451 (a)(2) Article 451 (a)(3)
EU LIQA – Management of liquidity risk
148 to 151
EU LIQ1- Quantitative information on the liquidity coverage ratio (LCR)
EU LIQUB on the qualitative information on the LCR ratio complementing the EU LIQ1 model
EU LIQ2 – Net Stable Funding Ratio
Article 442 (c) and (f)
EU CR1: performing and non-performing exposures and corresponding provisions
Article 442 (g)
EU CR1-A – Exposure maturity
Article 442 CRR (f)
EU CR2 – changes in the stock of non-performing loans and advances
Article 442 (c) Article 442 (d)
EU CQ1- Credit quality of forborne exposures
EU CQ3- Credit quality of performing and non-performing exposures by number of days past due
Article 442 (c) and (e) Article 442 (c) and (e)
EU CQ4- Quality of non-performing exposures by geography
EU CQ5- Credit quality of loans and advances granted to non-financial companies by industry
Article 442 (c)
EU CQ7- Collateral obtained by taking possession and execution processes
Article 453 (a) to (e)
EU CRC – Requirements to publish qualitative information on CRM techniques
122 to 131
Article 453 (f)
EU CR3 – Overview of CRM Techniques: disclosure of the use of CRM (Credit Risk Mitigation) techniques
Article 444 (a) to (d)
EU CRD – Requirements to publish qualitative information on the standardized approach
122 to 131
Article 453 CRR (g), (h) and (i) Article 444 (e)
EU CR4 – Standardized approach – Credit risk exposure and Credit Risk Mitigation (CRM) effects
Article 444 (e)
EU CR5 – Standardized approach
Article 452 (g) (i)-(v)
EU CR6 – IRB approach – Credit risk exposures by exposure class and PD range
Article 452 (b)
EU CR6-A – Scope of IRB and SA approaches
Article 453 (j)
EU CR7 – IRB approach – Effect on RWEA of credit derivatives used as CRM techniques
Article 453 (g) Article 438 (h) Article 452 (h) Article 438 (e)
EU CR7-A – IRB approach – Information to be published on the degree of use of CRM techniques
EU CR8 – RWA flow statements of CCR exposures under the IRB approach
EU CR9 – IRB approach – Post-exposure control of DPs by exposure category
EU CR10 – Specialized lending and equity exposures subject to the simple risk-weighted asset method
209 to 211 122 to 131
Article 439 (a) to (d)
EU CCRA – Qualitative disclosures related to counterparty credit risk
Article 439 (f), (g) and (k)
EU CCR1 – Analysis of CCR exposures by approach
Article 439 (h) Article 439 (l) Article 439 (l) Article 439 (e)
EU CCR2 – Transactions subject to capital requirement for CVA risk
EU CCR3 – Standardized approach – CCR exposures by regulatory exposure categories and weighting
EU CCR4 – IRB approach – Credit risk exposures by exposure class and PD range
EU CCR5 – Composition of collateral for CCR exposures
Article 439 (j)
EU CCR6 – Credit derivative exposures
Article 438 (h)
EU CCR7 – Statements of RWEA flows relating to CCR exposures under the IMM (internal model method)
Article 439 (i)
EU CCR8 – Exposures on a CCP
Article 449 (a) to (i)
EU-SECA – Qualitative disclosure requirements for securitization exposures
Article 449 (j) Article 449 (j)
EU-SEC1 – Securitization exposures in the non-trading book
EU-SEC2 – Securitization exposures in the trading book
Article 449 (k) (i) Article 449 (k) (ii)
EU-SEC3 – Securitization exposures in the non-trading book and associated regulatory capital requirements – institution acting as an originator or as a sponsor
EU-SEC4 – Securitization exposures in the non-trading book and associated regulatory capital requirements – institution acting as an investor
Article 449 (1)
EU-SEC5 – Exposures securitized by the institution – Exposures in default and specific credit risk adjustments
EU MRA: Requirements to publish qualitative information on market risk
136 to 139
Article 435(1) (a) to (g)
Article 445
EU MR1 – Market risk under the standardized approach
224
EU MRB: qualitative disclosure requirements for institutions using internal market risk models
136 to 139
Article 455 (a), (b), (c) and (f)
232
NATIXIS UNIVERSAL REGISTRATION DOCUMENT 2021
Made with FlippingBook Annual report maker